Back to MORGAN STANLEY MORGAN STANLEY

NGNENGNE
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NEUROGENE INC

MORGAN STANLEY holds 191,724 shares of NGNE (NEUROGENE INC), worth $6M as of 2026-Q2. The position was decreased (-32.8% shares). NGNE represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$6M

Current Shares

191,724

Total Value Change

-$8.9M

Total Shares Change

-164,701

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
191,724
-32.8%
$6M0.0%$31.45
0
2026-Q1
Decreased
285,239
-23.1%
$5.8M0.0%$21.99
0
2025-Q4
Decreased
371,174
-13.0%
$7.6M0.0%$22.11
0
2025-Q3
Decreased
426,576
-21.8%
$7.4M0.0%$17.71
0
2025-Q2
Increased
545,603
+90.7%
$8.2M0.0%$16.16
43
2025-Q1
Decreased
286,112
-13.3%
$3.4M0.0%$14.52
0
2024-Q4
Decreased
329,863
-7.5%
$7.5M0.0%$22.28
0
2024-Q3
Decreased
356,425
-6.9%
$15M0.0%$40.33
0

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used